Please use this identifier to cite or link to this item:
https://doi.org/10.1038/s41467-019-12017-8
Title: | Lung endothelial cell antigen cross-presentation to CD8+T cells drives malaria-associated lung injury | Authors: | Claser, C. Nguee, S.Y.T. Balachander, A. Wu Howland, S. Becht, E. Gunasegaran, B. Hartimath, S.V. Lee, A.W.Q. Theng Theng Ho, J. Bing Ong, C. Newell, E.W. Goggi, J. Guan Ng, L. Renia, L. |
Issue Date: | 2019 | Publisher: | Nature Publishing Group | Citation: | Claser, C., Nguee, S.Y.T., Balachander, A., Wu Howland, S., Becht, E., Gunasegaran, B., Hartimath, S.V., Lee, A.W.Q., Theng Theng Ho, J., Bing Ong, C., Newell, E.W., Goggi, J., Guan Ng, L., Renia, L. (2019). Lung endothelial cell antigen cross-presentation to CD8+T cells drives malaria-associated lung injury. Nature Communications 10 (1) : 4241. ScholarBank@NUS Repository. https://doi.org/10.1038/s41467-019-12017-8 | Rights: | Attribution 4.0 International | Abstract: | Malaria-associated acute respiratory distress syndrome (ARDS) and acute lung injury (ALI) are life-threatening manifestations of severe malaria infections. The pathogenic mechanisms that lead to respiratory complications, such as vascular leakage, remain unclear. Here, we confirm that depleting CD8+T cells with anti-CD8? antibodies in C57BL/6 mice infected with P. berghei ANKA (PbA) prevent pulmonary vascular leakage. When we transfer activated parasite-specific CD8+T cells into PbA-infected TCR??/? mice (devoid of all T-cell populations), pulmonary vascular leakage recapitulates. Additionally, we demonstrate that PbA-infected erythrocyte accumulation leads to lung endothelial cell cross-presentation of parasite antigen to CD8+T cells in an IFN??dependent manner. In conclusion, pulmonary vascular damage in ALI is a consequence of IFN?-activated lung endothelial cells capturing, processing, and cross-presenting malaria parasite antigen to specific CD8+T cells induced during infection. The mechanistic understanding of the immunopathogenesis in malaria-associated ARDS and ALI provide the basis for development of adjunct treatments. © 2019, The Author(s). | Source Title: | Nature Communications | URI: | https://scholarbank.nus.edu.sg/handle/10635/209515 | ISSN: | 2041-1723 | DOI: | 10.1038/s41467-019-12017-8 | Rights: | Attribution 4.0 International |
Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1038_s41467-019-12017-8.pdf | 4.42 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License